Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226360 | PMC |
| http://dx.doi.org/10.1002/jia2.25955 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Multi-omics characterization and machine learning of lung adenocarcinoma molecular subtypes to guide precise chemotherapy and immunotherapy.
Front Immunol
December 2024
Department of Anesthesiology, The First People's Hospital of Lianyungang, Lianyungang, Jiangsu, China.
Background: Lung adenocarcinoma (LUAD) is a heterogeneous tumor characterized by diverse genetic and molecular alterations. Developing a multi-omics-based classification system for LUAD is urgently needed to advance biological understanding.
Methods: Data on clinical and pathological characteristics, genetic alterations, DNA methylation patterns, and the expression of mRNA, lncRNA, and microRNA, along with somatic mutations in LUAD patients, were gathered from the TCGA and GEO datasets.
Turning the tide on healthy eating.
Br J Gen Pract
December 2024
Flexitarian south-east coast GP. Email:
Recent achievements and future directions of anti-obesity medications.
Lancet Reg Health Eur
December 2024
Institute for Diabetes and Obesity, Helmholtz Munich, Neuherberg, Germany.
Article Synopsis
- Recent advancements in pharmacological treatments for obesity, particularly with GLP-1 agonists and unimolecular peptides, have shifted the perception of obesity management from 'Mission Impossible' to a more feasible approach with promising results.
- These novel treatments not only aid in weight loss and blood sugar control for those with obesity and type 2 diabetes, but also show potential benefits for other health issues like neurodegenerative diseases and cardiovascular conditions.
- The review discusses the progress made in incretin-based therapies, their effectiveness and safety, as well as limitations and side effects associated with their use.
Turning the tide: pembrolizumab's triumph in adjuvant RCC therapy.
Med Oncol
September 2024
Oncology Department, Prince Sultan Military Medical City, Makkah Al Mukarramah Rd, As Sulimaniyah, Riyadh, 12233, Kingdom of Saudi Arabia.
In recent years, kidney cancer has shown an increased worldwide incidence of more than 400 000 novel cases annually. Although more than half of patients are diagnosed at a localised stage, this disease presents a high-risk of relapse after surgery. Thus, there is a need for adjuvant therapy post-resection to reduce cancer recurrence and prolong disease-free and overall survival.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!